| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Invited Review
1 Laboratory of Molecular Mouse Genetics, Institute of Toxicology, Johannes Gutenberg-University Mainz, D-55131 Mainz
2 Laboratory of Molecular Genetics at Children’s Hospital, Johannes Gutenberg-University Mainz, D-55101 Mainz, Germany
The ability to engineer the mouse genome has profoundly transformed biomedical research. During the last decade, conventional transgenic and gene knockout technologies have become invaluable experimental tools for modeling genetic disorders, assigning functions to genes, evaluating drugs and toxins, and by and large helping to answer fundamental questions in basic and applied research. In addition, the growing demand for more sophisticated murine models has also become increasingly evident. Good state-of-principle knowledge about the enormous potential of second-generation conditional mouse technology will be beneficial for any researcher interested in using these experimental tools. In this review we will focus on practice, pivotal principles, and progress in the rapidly expanding area of conditional mouse technology. The review will also present an internet compilation of available tetracycline-inducible mouse models as tools for biomedical research (http://www.zmg.uni-mainz.de/tetmouse/).
transgenic mice; knockout mice; conditional mouse models; Cre and Flp recombinase; tetracycline; doxycycline; IPTG; isopropyl-ß-D-thiogalactosidase; rapamycine; progesterone; RU486; ecdysone
This article has been cited by other articles:
|
|
 |
|
  G. Palais, A. Nguyen Dinh Cat, H. Friedman, N. Panek-Huet, A. Millet, F. Tronche, B. Gellen, J.-J. Mercadier, A. Peterson, and F. Jaisser Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system Physiol Genomics, April 10, 2009; 37(2): 140 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bao-Cutrona and P. Moral Unexpected Expression Pattern of Tetracycline-Regulated Transgenes in Mice Genetics, April 1, 2009; 181(4): 1687 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Matute-Bello, C. W. Frevert, and T. R. Martin Animal models of acute lung injury Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L379 - L399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S J Henare, D J Mellor, R G Lentle, and P J Moughan An appraisal of the strengths and weaknesses of newborn and juvenile rat models for researching gastrointestinal development Lab Anim, July 1, 2008; 42(3): 231 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hameyer, A. Loonstra, L. Eshkind, S. Schmitt, C. Antunes, A. Groen, E. Bindels, J. Jonkers, P. Krimpenfort, R. Meuwissen, et al. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues Physiol Genomics, September 11, 2007; 31(1): 32 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bockamp, C. Antunes, M. Maringer, R. Heck, K. Presser, S. Beilke, S. Ohngemach, R. Alt, M. Cross, R. Sprengel, et al. Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells Blood, September 1, 2006; 108(5): 1533 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lydic Sleep disruption is related to allelic variation in the ob gene Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R892 - R893. [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Wong, J. L Kolman, Y.-C. Li, L. D Mesner, W. Hillen, C. Berens, and G. M Wahl Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange Nucleic Acids Res., October 4, 2005; 33(17): e147 - e147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. de Magalhaes and G. M. Church Genomes Optimize Reproduction: Aging as a Consequence of the Developmental Program Physiology, August 1, 2005; 20(4): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. G. Smits, T. A. Peters, J. D. Mul, H. J. Croes, J. A. M. Fransen, A. J. Beynon, V. Guryev, R. H. A. Plasterk, and E. Cuppen Identification of a Rat Model for Usher Syndrome Type 1B by N-Ethyl-N-nitrosourea Mutagenesis-Driven Forward Genetics Genetics, August 1, 2005; 170(4): 1887 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Swanson, M. J. Mazur, K. Vashisht, L. A. Rund, J. E. Beever, C. M. Counter, and L. B. Schook Genomics and Clinical Medicine: Rationale for Creating and Effectively Evaluating Animal Models Experimental Biology and Medicine, October 1, 2004; 229(9): 866 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li, A. Rojas, J. Wu, and C. Jiang Disruption of Glucose Sensing and Insulin Secretion by Ribozyme Kir6.2-Gene Targeting in Insulin-Secreting Cells Endocrinology, September 1, 2004; 145(9): 4408 - 4414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Khairallah, F. Labarthe, B. Bouchard, G. Danialou, B. J. Petrof, and C. Des Rosiers Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1461 - H1470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Davisson Physiological genomic analysis of the brain renin-angiotensin system Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R498 - R511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Montrose The Future of GI and Liver Research: Editorial Perspectives: I. Visions of epithelial research Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G547 - G550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Glueck Note from the Deputy Editor Physiol Genomics, December 3, 2002; 11(3): 109 - 109. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
